Summit Therapeutics Inc. Annual Operating Lease, Payments in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Summit Therapeutics Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2017 to 2023.
  • Summit Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $367K, a 23.6% increase year-over-year.
  • Summit Therapeutics Inc. annual Operating Lease, Payments for 2023 was $2.21M, a 102% increase from 2022.
  • Summit Therapeutics Inc. annual Operating Lease, Payments for 2022 was $1.09M, a 4.9% increase from 2021.
  • Summit Therapeutics Inc. annual Operating Lease, Payments for 2021 was $1.04M, a 113% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.21M +$1.12M +102% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $1.09M +$51K +4.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $1.04M +$553K +113% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $488K +$53K +12.2% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-31
2019 $435K +$66K +17.9% Feb 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $369K +$187K +103% Feb 1, 2018 Jan 31, 2019 10-K 2021-03-31
2017 $182K Feb 1, 2017 Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.